Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2101034	注射用CMAB007	omalizumab	Lyophilized	Biological Products(3.4)	New Drug Application	2021-10-22		Taizhou Maibotaike Pharmaceutical Co Ltd			view
CXSS2101035	注射用CMAB007	omalizumab	Lyophilized	Biological Products(3.4)	New Drug Application	2021-10-22		Taizhou Maibotaike Pharmaceutical Co Ltd			view